Antegren
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Natalizumab (Tysabri®, formerly known as Antegren®, Elan Pharmaceuticals [Elan; San Francisco, CA, USA] and Biogen Idec [Biogen…
Natalizumab (Antegren™, Elan Corp. plc.; Biogen Idec.) is the first α4-integrin antagonist in the class of selective adhesion…
In this open-label drug-interaction trial, we studied 38 patients with relapsing-remitting multiple sclerosis (MS) who received 3…
Natalizumab (Antegren, Elan Corp. plc.; Biogen Idec.) is the first alpha4-integrin antagonist in the class of selective adhesion…
Natalizumab [AN 100226, anti-alpha4 integrin monoclonal antibody, Antegren] is a humanised monoclonal antibody that blocks…
ZusammenfassungAntegren (Natalizumab) ist ein “humanisierter” monoklonaler Antikörper, der an die α4-Untereinheit von α4β1…
Antegren (Natalizumab) is a humanized monoclonal antibody directed against alpha 4-integrin. This antibody binds to the alpha 4…
OBJECTIVE
To determine the effect of humanized monoclonal antibody against alpha4 integrin (reactive with alpha4beta1 integrin or…
Objective: To determine the effect of humanized monoclonal antibody against α4 integrin (reactive with α4β1 integrin or very-late…
AN-100226 (Antegren), a humanized monoclonal antibody (MAb) directed against the alpha4beta1 integrin (VLA-4) expressed on…